STOK
Stoke Therapeutics Inc
NASDAQ: STOK · HEALTHCARE · BIOTECHNOLOGY
$32.42
-2.73% today
Updated 2026-04-29
Market cap
$1.92B
P/E ratio
—
P/S ratio
10.40x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$8 – $40
Volume
0.8M
Stoke Therapeutics Inc (STOK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+43.0%
Last 4 quarters
Revenue YoY growth
-93.8%
Most recent quarter
EPS YoY growth
-438.9%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+28.5%
2025-08-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-11 | $-0.97 | -36.0% | $38.35 | $36.48 | -4.9% |
| 2025-11-04 | $-0.65 | -12.1% | $26.10 | $22.82 | -12.6% |
| 2025-08-12 | $-0.40 | +20.0% | $13.16 | $16.91 | +28.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.71 | $-0.97 | -36.0% | $1.40M | -93.8% |
| 2025-09-30 | $-0.58 | $-0.65 | -12.1% | $10.63M | +117.2% |
| 2025-06-30 | $-0.50 | $-0.40 | +20.0% | $13.82M | +186.0% |
| 2025-03-31 | $-0.09 | $1.90 | +2199.4% | $158.57M | +3661.1% |
| 2024-12-31 | $-0.53 | $-0.18 | +66.1% | $22.61M | +707.1% |
| 2024-09-30 | $-0.53 | $-0.47 | +11.5% | $4.89M | +47.9% |
| 2024-06-30 | $-0.56 | $-0.46 | +17.9% | $4.83M | -294.7% |
| 2024-03-31 | $-0.61 | $-0.57 | +6.6% | $4.22M | — |
| 2023-12-31 | $-0.63 | $-0.60 | +4.8% | $2.80M | — |
| 2023-09-30 | $-0.63 | $-0.55 | +12.7% | $3.31M | — |
| 2023-06-30 | $-0.64 | $-0.69 | -7.8% | $-2.48M | — |
Frequently asked questions
Has Stoke Therapeutics Inc beaten earnings estimates?
Stoke Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +43.0% over the last 4 quarters.
How does STOK stock react to earnings?
STOK stock has moved an average of +3.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Stoke Therapeutics Inc's revenue growth rate?
Stoke Therapeutics Inc reported year-over-year revenue growth of -93.8% in its most recent quarter, with EPS growing -438.9% year-over-year.